OR32. Efficacy and Safety of Therapeutic Versus Prophylactic Dose of Anticoagulation in Hospitalized Patients with Severe COVID-19 Pneumonia and Coagulopathy: An Open-Label, Randomized Controlled Trial

被引：0
|
作者：
Adrian, L. H. [1 ]
Hutomo, S. A. [1 ]
Negari, A. D. S. [1 ]
机构：
[1] Syarifah Ambami Rato Ebu Gen Hosp, Dept Cardiol & Vasc Med, East Java, Indonesia
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2021年 / 23卷 / SUPPL F期
关键词：
COVID-19; coagulopathy; therapeutic; anticoagulant; efficacy; safety;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia
    Varona, Jose F.
    Nunez, Elena
    Felix, Borja M. Fernandez
    Vazquez, Jose Maria Castellano
    Cubillo, Antonio
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 99 : 106 - 108
  • [42] Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
    Rosas, Ivan O.
    Diaz, George
    Gottlieb, Robert L.
    Lobo, Suzana M.
    Robinson, Philip
    Hunter, Bradley D.
    Cavalcante, Adilson W.
    Overcash, J. Scott
    Hanania, Nicola A.
    Skarbnik, Alan
    Garcia-Diaz, Julia
    Gordeev, Ivan
    Carratala, Jordi
    Gordon, Oliver
    Graham, Emily
    Lewin-Koh, Nicholas
    Tsai, Larry
    Tuckwell, Katie
    Cao, Huyen
    Brainard, Diana
    Olsson, Julie K.
    INTENSIVE CARE MEDICINE, 2021, 47 (11) : 1258 - 1270
  • [43] High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial
    Naik, Naveen B.
    Puri, Goverdhan D.
    Kajal, Kamal
    Mahajan, Varun
    Bhalla, Ashish
    Kataria, Sandeep
    Singla, Karan
    Panigrahi, Pritam
    Singh, Ajay
    Lazar, Michelle
    Chander, Anjuman
    Ganesh, Venkata
    Hazarika, Amarjyoti
    Suri, Vikas
    Goyal, Manoj K.
    Pandey, Vijayant Kumar
    Kaloria, Narender
    Samra, Tanvir
    Saini, Kulbhushan
    Soni, Shiv L.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [44] Efficacy and safety of vitamin D supplementation in hospitalized COVID-19 pediatric patients: A randomized controlled trial
    Zurita-Cruz, Jessie
    Fonseca-Tenorio, Jeffry
    Villasis-Keever, Miguel
    Lopez-Alarcon, Mardia
    Parra-Ortega, Israel
    Lopez-Martinez, Briceida
    Miranda-Novales, Guadalupe
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [45] Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study
    Balkhair, A.
    Al-Zakwani, I.
    Busaidi, M. Al
    Al-Khirbash, A.
    Mubaihsi, S. Al
    BaTaher, H.
    Aghbari, J. Al
    Busaidi, I. Al
    Kindi, M. Al
    Baawain, S.
    Alawi, A. Al
    Lawati, A. Al
    Rawahi, B. Al
    Al-Baimani, K.
    Zidi, K. Al
    Elfatih, N.
    Dawud, B.
    John, B.
    Rehman, F.
    Yousif, F.
    Khadouri, G. Al
    Saber, I.
    Lal, J.
    Gargouri, M.
    Al-Ward, M.
    AbuDraz, N.
    Al Ruqeishi, S.
    Kumar, S.
    Abdelmottaleb, W.
    Al-Naamani, Z.
    Bin Nazar, Z.
    Balkhair, O.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 103 : 288 - 296
  • [46] Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial
    Chen, Chang
    Zhang, Yi
    Huang, Jianying
    Yin, Ping
    Cheng, Zhenshun
    Wu, Jianyuan
    Chen, Song
    Zhang, Yongxi
    Chen, Bo
    Lu, Mengxin
    Luo, Yongwen
    Ju, Lingao
    Zhang, Jingyi
    Wang, Xinghuan
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [47] Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol
    Marietta, Marco
    Vandelli, Paola
    Mighali, Pasquale
    Vicini, Roberto
    Coluccio, Valeria
    D'Amico, Roberto
    TRIALS, 2020, 21 (01)
  • [48] Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial
    Blondon, Marc
    Cereghetti, Sara
    Pugin, Jerome
    Marti, Christophe
    Farhoumand, Pauline Darbellay
    Reny, Jean-Luc
    Calmy, Alexandra
    Combescure, Christophe
    Mazzolai, Lucia
    Pantet, Olivier
    Ltaief, Zied
    Mean, Marie
    Besson, Sara Manzocchi
    Jeanneret, Severin
    Stricker, Hans
    Robert-Ebadi, Helia
    Fontana, Pierre
    Righini, Marc
    Casini, Alessandro
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (04)
  • [49] Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol
    Marco Marietta
    Paola Vandelli
    Pasquale Mighali
    Roberto Vicini
    Valeria Coluccio
    Roberto D’Amico
    Trials, 21
  • [50] Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial
    Diago-Sempere, Elena
    Bueno, Jose Luis
    Sancho-Lopez, Aranzazu
    Rubio, Elena Munez
    Torres, Ferran
    de Molina, Rosa Malo
    Fernandez-Cruz, Ana
    de Diego, Isabel Salcedo
    Velasco-Iglesias, Ana
    Payares-Herrera, Concepcion
    Flecha, Inmaculada Casas
    Avendano-Sola, Cristina
    Palomino, Rafael Duarte
    Ramos-Martinez, Antonio
    Ruiz-Antoran, Belen
    TRIALS, 2021, 22 (01)
12345